Epic Bio

Epic Bio, headquartered in South San Francisco, California, is a biotechnology company founded in 2018 by CRISPR pioneer Stanley Qi. The company specializes in developing ultracompact therapies to modulate gene expression using advanced epigenetic engineering techniques. Epic Bio leverages the power of CRISPR technology without cutting DNA, utilizing the smallest known Cas protein, CasMINI, to achieve precise gene regulation. Their proprietary Gene Expression Modulation platform aims to revolutionize genetic medicine, with a focus on creating durable gene activators and advancing therapies such as EPI-321 for conditions like FSHD (Facioscapulohumeral Muscular Dystrophy).

Recent Posts by Epic Bio

1-1 of 1